PFSA · Profusa, Inc.
$0.88
-0.02 (-2.24%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, there continue to be factors which raise substantial doubt about the Company's ability to continue as a going concern within one year from the date the condensed consolidated financial statements are issued.”View the 10-Q filed Aug 19, 2026
Market Cap
$545,203
Shares
605,647
Volume · Oct 20
106.64K
Avg daily vol (45 sessions)
3.93M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.90
Open$0.93
Day$0.88–0.94
52W close$0.90–2,415.00
Avg vol 30d3.7M
Short int161K · 26.5% float · 1.0d
Short vol38%
DataJul 2025–Oct 2026
Filing10-Q · Aug 19
Up next
filed Aug 19, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$42.97M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
-4,500.0%
Trailing 12 months
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 950,008.9%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+22,255.0%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
26.5%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−99%
below
Price vs 50-day avg
−73%
below
RSI (14)
37
neutral
MACD trend
Positive
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−54%
trailing
6-month return
−98%
trailing
YTD return
−100%
this year
Relative strength
−106%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $126 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
26.53% of float · ▲ +409.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
10 holders — mid 3-yr range
Squeeze score
64
elevated · 0–100
Fundamentals
EPS growth
+70%
Y/Y
Free cash flow
$-16.3M
Quant / Vol
risk profile
Volatility
568%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
57.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−99%
Bearish
Price vs 50-day avg
−73%
Bearish
RSI (14)
37
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $3 › 200d $126 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
26.53% of float · ▲ +409.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
10 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 0%
Range high $2,415
vs 200-day avg -99%
vs 50-day avg -73%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PFSA
this stock
Profusa, Inc.
|
$545,203 | — | — | — | 26.5% |
|
ABT
Abbott Laboratories
|
$180.99B | -16.9% | +5.7% | 33.6 | 0.8% |
|
MDT
Medtronic plc
|
$118.67B | -3.4% | +8.4% | 22.9 | 3.1% |
|
SYK
Stryker Corp
|
$114.28B | -15.2% | +11.2% | 30.9 | 1.5% |
|
BSX
Boston Scientific Corp
|
$65.16B | -52.8% | +12.5% | 18.2 | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
SEC Filings
Latest
8-K
- Filed
- Oct 15, 2026
- This year
- 42
Profusa, Inc. issued Ascent Partners Fund LLC a $769,230.77 senior secured convertible promissory note for $700,000.00, bearing 7% interest, convertible at $4.28 per share with a $1.07 floor, maturing earlier of October 15, 2027 and the Option Closing Date.
ViewEarnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PFSA | -30.8% | -53.6% | -98.4% | -54.5% | -99.9% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -29.3% | -52.7% | -106.1% | -55.0% | -112.3% |